Literature DB >> 16584928

Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levodopa, 3-O-methyldopa, dopamine, carbidopa and 3,4-dihydroxyphenyl acetic acid.

Morvarid Karimi1, Juanita L Carl, Susan Loftin, Joel S Perlmutter.   

Abstract

Plasma measurements of levodopa and its major metabolites including dopamine and 3-O-methyldopa have been limited by cumbersome methods and poor sensitivity within relatively narrow ranges of plasma levels. We now report a modification of an HPLC method that permits concomitant measurements of a wide range of concentrations of levodopa, dopamine (DA), carbidopa, 3-O-methyldopa (3-OMD) and 3,4-dihydroxyphenyl acetic acid (DOPAC) from one HPLC injection. The recoveries ranged from 77 to 107% with an intra-day precision around 5% (CV) and inter-day CV's about 10-20%. This validated method will simplify pharmacokinetic studies of levodopa and its metabolites for mechanistic studies or therapeutic clinical monitoring which play a crucial role in development of strategies to prolong motor benefits from individual doses and reduce involuntary movements called dykinesias.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16584928     DOI: 10.1016/j.jchromb.2006.03.027

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  17 in total

1.  Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates.

Authors:  Laura L Dugan; LinLin Tian; Kevin L Quick; Josh I Hardt; Morvarid Karimi; Chris Brown; Susan Loftin; Hugh Flores; Stephen M Moerlein; John Polich; Samer D Tabbal; Jonathan W Mink; Joel S Perlmutter
Journal:  Ann Neurol       Date:  2014-07-22       Impact factor: 10.422

2.  3-Dimensional hollow graphene balls for voltammetric sensing of levodopa in the presence of uric acid.

Authors:  Xin Gao; Hongyan Yue; Shanshan Song; Shuo Huang; Bing Li; Xuanyu Lin; Erjun Guo; Bao Wang; Enhao Guan; Hongjie Zhang; Pengfei Wu
Journal:  Mikrochim Acta       Date:  2018-01-10       Impact factor: 5.833

3.  Little Change in Functional Brain Networks Following Acute Levodopa in Drug-Naïve Parkinson's Disease.

Authors:  Robert L White; Meghan C Campbell; Dake Yang; William Shannon; Abraham Z Snyder; Joel S Perlmutter
Journal:  Mov Disord       Date:  2019-12-19       Impact factor: 10.338

4.  Validation of nigrostriatal positron emission tomography measures: critical limits.

Authors:  Morvarid Karimi; LinLin Tian; Christopher A Brown; Hubert P Flores; Susan K Loftin; Tom O Videen; Stephen M Moerlein; Joel S Perlmutter
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

5.  Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration.

Authors:  Ki Sung Kang; Noriko Yamabe; Yujing Wen; Masayuki Fukui; Bao Ting Zhu
Journal:  Brain Res       Date:  2012-12-01       Impact factor: 3.252

6.  Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques.

Authors:  Christopher A Brown; Morvarid K Karimi; LinLin Tian; Hugh Flores; Yi Su; Samer D Tabbal; Susan K Loftin; Stephen M Moerlein; Joel S Perlmutter
Journal:  Ann Neurol       Date:  2013-09-16       Impact factor: 10.422

7.  Low nigrostriatal reserve for motor parkinsonism in nonhuman primates.

Authors:  Samer D Tabbal; Linlin Tian; Morvarid Karimi; Christopher A Brown; Susan K Loftin; Joel S Perlmutter
Journal:  Exp Neurol       Date:  2012-07-24       Impact factor: 5.330

8.  Toward the understanding of the metabolism of levodopa I. DFT investigation of the equilibrium geometries, acid-base properties and levodopa-water complexes.

Authors:  Shabaan A K Elroby; Mohamed S I Makki; Tariq R Sobahi; Rifaat H Hilal
Journal:  Int J Mol Sci       Date:  2012-04-02       Impact factor: 6.208

9.  Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies.

Authors:  Ki Sung Kang; Yujing Wen; Noriko Yamabe; Masayuki Fukui; Stephanie C Bishop; Bao Ting Zhu
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

10.  No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease.

Authors:  LinLin Tian; Morvarid Karimi; Susan K Loftin; Chris A Brown; HuChuan Xia; JinBin Xu; Robert H Mach; Joel S Perlmutter
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.